| Annette Melanie Vollrath, MD | |
|
1400 E Palomar St, Chula Vista, CA 91913-1800 | |
| (858) 499-2616 | |
| Not Available |
| Full Name | Annette Melanie Vollrath |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 1400 E Palomar St, Chula Vista, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992884415 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sharp Chula Vista Medical Center | Chula vista, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sharp Rees-stealy Medical Group Inc | 8628972759 | 772 |
| Emergency And Acute Care Medical Corporation | 9537108279 | 382 |
News Archive
Cells in our body are constantly dividing to maintain our body functions. At each division, our DNA code and a whole machinery of supporting components has to be faithfully duplicated to maintain the cell's memory of its own identity.
A study posted today (Wednesday, August 25) at the online site of the journal Biology of Reproduction reports that exposure of pregnant female mice to the endocrine-disrupting chemical bisphenol A may produce adverse reproductive consequences on gene expression in fetal ovaries as early as 12 hours after the mother has first been exposed to the chemical.
Trusts are far better prepared to deal with patients injured in chemical incidents following national training but the design and distribution of chemical protective suits and shelters are still a problem, says research published this week in Emergency Medicine Journal.
Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration of Desoximetasone Ointment USP 0.25%, the generic equivalent of Topicort Ointment, 0.25%, of Taro Pharmaceuticals U.S.A., Inc.
Researchers at the University of East Anglia have discovered for the first time a pathway that makes cancerous leukaemia cells resistant to treatment.
› Verified 8 days ago
| Entity Name | Sharp Rees-stealy Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285616177 PECOS PAC ID: 8628972759 Enrollment ID: O20031120000996 |
News Archive
Cells in our body are constantly dividing to maintain our body functions. At each division, our DNA code and a whole machinery of supporting components has to be faithfully duplicated to maintain the cell's memory of its own identity.
A study posted today (Wednesday, August 25) at the online site of the journal Biology of Reproduction reports that exposure of pregnant female mice to the endocrine-disrupting chemical bisphenol A may produce adverse reproductive consequences on gene expression in fetal ovaries as early as 12 hours after the mother has first been exposed to the chemical.
Trusts are far better prepared to deal with patients injured in chemical incidents following national training but the design and distribution of chemical protective suits and shelters are still a problem, says research published this week in Emergency Medicine Journal.
Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration of Desoximetasone Ointment USP 0.25%, the generic equivalent of Topicort Ointment, 0.25%, of Taro Pharmaceuticals U.S.A., Inc.
Researchers at the University of East Anglia have discovered for the first time a pathway that makes cancerous leukaemia cells resistant to treatment.
› Verified 8 days ago
| Entity Name | Emergency And Acute Care Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437103942 PECOS PAC ID: 9537108279 Enrollment ID: O20050502000734 |
News Archive
Cells in our body are constantly dividing to maintain our body functions. At each division, our DNA code and a whole machinery of supporting components has to be faithfully duplicated to maintain the cell's memory of its own identity.
A study posted today (Wednesday, August 25) at the online site of the journal Biology of Reproduction reports that exposure of pregnant female mice to the endocrine-disrupting chemical bisphenol A may produce adverse reproductive consequences on gene expression in fetal ovaries as early as 12 hours after the mother has first been exposed to the chemical.
Trusts are far better prepared to deal with patients injured in chemical incidents following national training but the design and distribution of chemical protective suits and shelters are still a problem, says research published this week in Emergency Medicine Journal.
Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration of Desoximetasone Ointment USP 0.25%, the generic equivalent of Topicort Ointment, 0.25%, of Taro Pharmaceuticals U.S.A., Inc.
Researchers at the University of East Anglia have discovered for the first time a pathway that makes cancerous leukaemia cells resistant to treatment.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Annette Melanie Vollrath, MD 1400 E Palomar St, Chula Vista, CA 91913-1800 Ph: (858) 499-2616 | Annette Melanie Vollrath, MD 1400 E Palomar St, Chula Vista, CA 91913-1800 Ph: (858) 499-2616 |
News Archive
Cells in our body are constantly dividing to maintain our body functions. At each division, our DNA code and a whole machinery of supporting components has to be faithfully duplicated to maintain the cell's memory of its own identity.
A study posted today (Wednesday, August 25) at the online site of the journal Biology of Reproduction reports that exposure of pregnant female mice to the endocrine-disrupting chemical bisphenol A may produce adverse reproductive consequences on gene expression in fetal ovaries as early as 12 hours after the mother has first been exposed to the chemical.
Trusts are far better prepared to deal with patients injured in chemical incidents following national training but the design and distribution of chemical protective suits and shelters are still a problem, says research published this week in Emergency Medicine Journal.
Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration of Desoximetasone Ointment USP 0.25%, the generic equivalent of Topicort Ointment, 0.25%, of Taro Pharmaceuticals U.S.A., Inc.
Researchers at the University of East Anglia have discovered for the first time a pathway that makes cancerous leukaemia cells resistant to treatment.
› Verified 8 days ago
Dr. Perry V Montoya, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 3rd Ave, Chula Vista, CA 91910 Phone: 858-499-2600 Fax: 619-585-4353 | |
John S Videen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 752 Medical Center Ct, Suite 302, Chula Vista, CA 91911 Phone: 619-421-3361 Fax: 619-656-8936 | |
Daniel Cepin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 890 Eastlake Pkwy, Suite 205, Chula Vista, CA 91914 Phone: 619-482-0300 Fax: 619-482-0959 | |
Kenneth Burton Johnson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 769 Medical Center Ct, Suite 202, Chula Vista, CA 91911 Phone: 619-482-8430 Fax: 619-482-8005 | |
Dr. Michael Sonbaty, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 E Palomar St, Chula Vista, CA 91913 Phone: 858-499-2616 | |
Sara Khandan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 835 Third Ave Ste A, Chula Vista, CA 91911 Phone: 619-425-7755 Fax: 619-425-2138 | |
Alejandro G Hinojosa, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 340 4th Ave, Suite 8, Chula Vista, CA 91910 Phone: 619-216-7546 Fax: 619-216-7783 |